AVB vs MREO · P/E 23, rev $3.04B vs $48.7M cap
AvalonBay Communities Inc (AVB) versus Mereo BioPharma Group PLC ADR (MREO) — a side-by-side from cached financials, not a winner call.
AvalonBay Communities Inc (AVB) is a reit - residential company listed on US.
Mereo BioPharma Group PLC ADR (MREO) is a biotechnology company listed on US.
Latest reported AVB revenue for 2025-12-31 was $3.04B. Net income was $1.06B. Revenue was up 4.4% from 2024-12-31 to 2025-12-31. AVB currently screens at market cap $26.84B and trailing P/E 23.4.
Latest reported MREO revenue for 2026-06-30 was $0. Net income was -$7.0M. Revenue was down 100.0% from 2026-03-31 to 2026-06-30. MREO currently screens at market cap $48.7M.
AVB currently screens at market cap $26.84B and trailing P/E 23.4. MREO currently screens at market cap $48.7M.
Not investment advice. Open the AVB and MREO stock pages for the full models.
Not investment advice.